Αποτελέσματα Αναζήτησης
Revolutionary infusion pump technology based on pneumatics rather than mechanics with huge safety / clinical / economic benefits for payors, providers, patients. Cardinal Partners is founding investor providing regulatory planning, investor syndicate and strategic partnering.
- Team
The operating and investment backgrounds of the Cardinal’s...
- Companies
Cardinal Partners is lead investor, raising capital and IPO...
- Our Vision
Our Vision. We are in a unique period of time where...
- Contact
Princeton Office (HQ) 230 Nassau Street, Princeton, NJ 08542...
- Venture Partners
Venture Partners; Venture Partners Together we can achieve...
- John Clarke
John currently serves on the Board of Directors for Cardinal...
- Thomas Mckinley
Thomas McKinley has over 35 years of venture capital...
- Events
© 2019 Cardinal Partners. All rights reserved. Scroll to top
- Team
Cardinal Partners is a venture capital partnership focused exclusively on healthcare investing.
Founded in 1996, Cardinal Partners is a venture capital firm based in Princeton, New Jersey. The firm prefers to invest in the healthcare, consumer, machine learning, blockchain, technology, and life sciences sectors.
John currently serves on the Board of Directors for Cardinal portfolio companies Abide Therapeutics, aTyr Pharma, Ivenix , and Vividion Therapeutics, as well as Alnylam Pharmaceuticals. John entered the venture industry in 1982 with DSV Partners, a pioneer venture capital fund formed in 1968.
Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies | Cardinal Partners has extensive experience in starting, incubating and investing...
VC investing group Cardinal Partners provides capital to innovative tech companies.
Our Vision. We are in a unique period of time where technology advances in all sectors can be leveraged to significantly transform healthcare. The transition from paper to digital combined with machine learning, changes the entire healthcare and life sciences landscape.